Card | Table | RUSMARC | |
De Gruyter STEM.
|
Annotation
The book reviews the history of current brand and generic business in pharmaceuticals manufacturing practices. Based on examples, the reader can interpolate, extrapolate and exploit mutual behavior (physical and chemical properties) of chemicals to design and commercialize processes that fulfill the demands, also manipulate chemical unit processes and unit operations to reduce/minimize effluents and lower environmental impact i.e. reduce global warming. Readers will be able to simplify process development, design and commercialize ecanufacturing processes.
Document access rights
Network | User group | Action | ||||
---|---|---|---|---|---|---|
Finuniversity Local Network | All |
![]() ![]() ![]() |
||||
Internet | Readers |
![]() ![]() |
||||
![]() |
Internet | Anonymous |
Table of Contents
- Preface
- Contents
- Chapter 1 History of pharmaceuticals
- Chapter 2 Business model: brand versus generics, product demand, process selection, and economics
- Chapter 3 Physical and chemical properties
- Chapter 4 Pharma chemistry/chemical development
- Chapter 5 Manufacturing process development and case studies
- Chapter 6 Active pharmaceutical ingredients (API): innovation, design considerations, and waste reduction
- Chapter 7 Process documentation and operating strategies
- Chapter 8 Road Map
- Index
Usage statistics
|
Access count: 0
Last 30 days: 0 Detailed usage statistics |